APA aipamena

Lu, X., Xiao, L., Wang, L., & Ruden, D. M. (2011). Hsp90 Inhibitors and Drug Resistance in Cancer: The Potential Benefits of Combination Therapies of Hsp90 Inhibitors and Other Anti-Cancer Drugs.

Chicago Style aipamena

Lu, Xiangyi, Li Xiao, Luan Wang, and Douglas M. Ruden. Hsp90 Inhibitors and Drug Resistance in Cancer: The Potential Benefits of Combination Therapies of Hsp90 Inhibitors and Other Anti-Cancer Drugs. 2011.

MLA aipamena

Lu, Xiangyi, Li Xiao, Luan Wang, and Douglas M. Ruden. Hsp90 Inhibitors and Drug Resistance in Cancer: The Potential Benefits of Combination Therapies of Hsp90 Inhibitors and Other Anti-Cancer Drugs. 2011.